Evaxion A (EVAX) Return on Capital Employed [ROCE] (2021 - 2026)
Evaxion A (EVAX) reported Return on Capital Employed [ROCE] of -47.31% for Q2 2026, up 28.07 percentage points from -75.39% a year earlier and up 11.63 percentage points from the prior quarter.
Powered by 
Analysis
Evaxion A (EVAX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, Evaxion A posted Return on Capital Employed [ROCE] of -57.04%.
- Return on Capital Employed [ROCE] has a five-year change of +194.09 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -213.99% in FY2023 (-68.56 pp), -145.43% in FY2022 (-67.66 pp) and -77.77% in FY2021 (+173.36 pp).
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -15538.14% in Q3 2024 and a high of -37.23% in Q4 2025.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2025 (a gain of 15467.05 percentage points); the low point was Q1 2023 (a drop of 222.13 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -58.94% (Q1 2026), -37.23% (Q4 2025) and -71.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Evaxion A | 20.38 Mn | -45.87 Mn | - | -47.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.31% |
| Mar 31, 2026 | -58.94% |
| Dec 31, 2025 | -37.23% |
| Sep 30, 2025 | -71.09% |
| Jun 30, 2025 | -75.39% |
| Mar 31, 2025 | -358.14% |
| Sep 30, 2024 | -15,538.14% |
| Jun 30, 2024 | -126.33% |
| Dec 31, 2023 | -418.79% |
| Jun 30, 2023 | -170.27% |
| Mar 31, 2023 | -345.78% |
| Dec 31, 2022 | -229.41% |
| Sep 30, 2022 | -157.26% |
| Jun 30, 2022 | -79.34% |
| Mar 31, 2022 | -75.29% |
| Dec 31, 2021 | -92.87% |
| Sep 30, 2021 | -103.64% |
| Jun 30, 2021 | -81.31% |
| Mar 31, 2021 | -105.88% |
API Access
Evaxion A Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();